Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bellamy

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Current Medical Research and Opinion|February 19, 2008
Topical diclofenac and its role in pain and inflammation: an evidence-based reviewJ Zacher, R Altman, N Bellamy, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
Guidelines for testing slow acting drugs in osteoarthritisM Lequesne, K Brandt, N Bellamy, et al.
The Journal of Rheumatology|July 1, 1995
Guidelines for testing slow acting drugs in arthritis--addendumM Lequesne, K Brandt, N Bellamy, et al.
The Journal of Rheumatology|May 6, 1999
Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IVD van der Heijde, S van der Linden, N Bellamy, et al.
The Journal of Rheumatology|April 1, 2000
Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or kneeP M Peloso, N Bellamy, W Bensen, et al.
The Journal of Rheumatology|November 28, 2000
Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritisE W Ehrich, G M Davies, D J Watson, et al.
The Journal of Rheumatology|February 7, 1998
Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working GroupD van der Heijde, N Bellamy, A Calin, et al.
The Journal of Rheumatology|May 6, 1999
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing SpondylitisD van der Heijde, A Calin, M Dougados, et al.
The Journal of Rheumatology|May 6, 1999
Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instrumentsD van der Heijde, S van der Linden, M Dougados, et al.
Osteoarthritis and Cartilage|March 3, 2018
A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trialD Aitken, L L Laslett, F Pan, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Current Medical Research and Opinion|February 19, 2008
Topical diclofenac and its role in pain and inflammation: an evidence-based reviewJ Zacher, R Altman, N Bellamy, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
Guidelines for testing slow acting drugs in osteoarthritisM Lequesne, K Brandt, N Bellamy, et al.
The Journal of Rheumatology|July 1, 1995
Guidelines for testing slow acting drugs in arthritis--addendumM Lequesne, K Brandt, N Bellamy, et al.
The Journal of Rheumatology|May 6, 1999
Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IVD van der Heijde, S van der Linden, N Bellamy, et al.
The Journal of Rheumatology|April 1, 2000
Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or kneeP M Peloso, N Bellamy, W Bensen, et al.
The Journal of Rheumatology|November 28, 2000
Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritisE W Ehrich, G M Davies, D J Watson, et al.
The Journal of Rheumatology|February 7, 1998
Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working GroupD van der Heijde, N Bellamy, A Calin, et al.
The Journal of Rheumatology|May 6, 1999
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing SpondylitisD van der Heijde, A Calin, M Dougados, et al.
The Journal of Rheumatology|May 6, 1999
Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instrumentsD van der Heijde, S van der Linden, M Dougados, et al.
Osteoarthritis and Cartilage|March 3, 2018
A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trialD Aitken, L L Laslett, F Pan, et al.
Pageof 16